AG
FLXN

Aperio Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Aperio Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,742
Closed -$46K – 2923
2019
Q2 		$46K Buy
+3,742
New +$46K ﹤0.01% 2551